1. Home
  2. CPZ vs ABEO Comparison

CPZ vs ABEO Comparison

Compare CPZ & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

SELL

Current Price

$12.75

Market Cap

246.8M

Sector

Finance

ML Signal

SELL

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

SELL

Current Price

$4.21

Market Cap

282.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CPZ
ABEO
Founded
N/A
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.8M
282.5M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
CPZ
ABEO
Price
$12.75
$4.21
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $18.88
AVG Volume (30 Days)
70.5K
★ 988.9K
Earning Date
01-01-0001
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 165.16
EPS
★ N/A
N/A
Revenue
N/A
★ $2,998,000.00
Revenue This Year
N/A
$804.33
Revenue Next Year
N/A
$119.68
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 258.18
52 Week Low
$12.27
$4.00
52 Week High
$15.34
$7.65

Technical Indicators

Market Signals
Indicator
CPZ
ABEO
Relative Strength Index (RSI) 50.29 33.80
Support Level $12.34 N/A
Resistance Level $12.79 $5.91
Average True Range (ATR) 0.22 0.22
MACD 0.03 0.02
Stochastic Oscillator 58.62 14.40

Price Performance

Historical Comparison
CPZ
ABEO

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: